Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.72 USD | -1.12% | +13.73% | +165.35% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.35% | 346M | |
-3.13% | 102B | |
+1.90% | 96.29B | |
+2.27% | 22.18B | |
-15.25% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.11% | 16.36B | |
+5.43% | 13.97B | |
+31.96% | 12.17B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Lowers Price Target on Homology Medicines to $8 From $10, Keeps Buy Rating